Cargando…

P871: IDECABTAGENE VICLEUCEL (IDE-CEL) IN PATIENTS WITH AN INADEQUATE RESPONSE TO FRONTLINE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): RESULTS FROM KARMMA-2 COHORT 2C

Detalles Bibliográficos
Autores principales: Alsina, Melissa, Dhodapkar, Madhav, Berdeja, Jesus, Patel, Krina, Richard, Shambavi, Vij, Ravi, Leleu, Xavier, Egan, Daniel, Leif Bergsagel, P., Ran, Reshef, Usmani, Saad Z, Truppel-Hartmann, Anna, Basudhar, Debashree, Thompson, Ethan, Zheng, Xirong, Zhong, Xiaobo, Greggio, Chiara, Popa Mckiver, Mihaela, Carrasco Alfonso, Marlene, Siegel, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431112/
http://dx.doi.org/10.1097/01.HS9.0000970388.90596.a3
_version_ 1785091122711756800
author Alsina, Melissa
Dhodapkar, Madhav
Berdeja, Jesus
Patel, Krina
Richard, Shambavi
Vij, Ravi
Leleu, Xavier
Egan, Daniel
Leif Bergsagel, P.
Ran, Reshef
Usmani, Saad Z
Truppel-Hartmann, Anna
Basudhar, Debashree
Thompson, Ethan
Zheng, Xirong
Zhong, Xiaobo
Greggio, Chiara
Popa Mckiver, Mihaela
Carrasco Alfonso, Marlene
Siegel, David
author_facet Alsina, Melissa
Dhodapkar, Madhav
Berdeja, Jesus
Patel, Krina
Richard, Shambavi
Vij, Ravi
Leleu, Xavier
Egan, Daniel
Leif Bergsagel, P.
Ran, Reshef
Usmani, Saad Z
Truppel-Hartmann, Anna
Basudhar, Debashree
Thompson, Ethan
Zheng, Xirong
Zhong, Xiaobo
Greggio, Chiara
Popa Mckiver, Mihaela
Carrasco Alfonso, Marlene
Siegel, David
author_sort Alsina, Melissa
collection PubMed
description
format Online
Article
Text
id pubmed-10431112
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104311122023-08-17 P871: IDECABTAGENE VICLEUCEL (IDE-CEL) IN PATIENTS WITH AN INADEQUATE RESPONSE TO FRONTLINE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): RESULTS FROM KARMMA-2 COHORT 2C Alsina, Melissa Dhodapkar, Madhav Berdeja, Jesus Patel, Krina Richard, Shambavi Vij, Ravi Leleu, Xavier Egan, Daniel Leif Bergsagel, P. Ran, Reshef Usmani, Saad Z Truppel-Hartmann, Anna Basudhar, Debashree Thompson, Ethan Zheng, Xirong Zhong, Xiaobo Greggio, Chiara Popa Mckiver, Mihaela Carrasco Alfonso, Marlene Siegel, David Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431112/ http://dx.doi.org/10.1097/01.HS9.0000970388.90596.a3 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Alsina, Melissa
Dhodapkar, Madhav
Berdeja, Jesus
Patel, Krina
Richard, Shambavi
Vij, Ravi
Leleu, Xavier
Egan, Daniel
Leif Bergsagel, P.
Ran, Reshef
Usmani, Saad Z
Truppel-Hartmann, Anna
Basudhar, Debashree
Thompson, Ethan
Zheng, Xirong
Zhong, Xiaobo
Greggio, Chiara
Popa Mckiver, Mihaela
Carrasco Alfonso, Marlene
Siegel, David
P871: IDECABTAGENE VICLEUCEL (IDE-CEL) IN PATIENTS WITH AN INADEQUATE RESPONSE TO FRONTLINE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): RESULTS FROM KARMMA-2 COHORT 2C
title P871: IDECABTAGENE VICLEUCEL (IDE-CEL) IN PATIENTS WITH AN INADEQUATE RESPONSE TO FRONTLINE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): RESULTS FROM KARMMA-2 COHORT 2C
title_full P871: IDECABTAGENE VICLEUCEL (IDE-CEL) IN PATIENTS WITH AN INADEQUATE RESPONSE TO FRONTLINE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): RESULTS FROM KARMMA-2 COHORT 2C
title_fullStr P871: IDECABTAGENE VICLEUCEL (IDE-CEL) IN PATIENTS WITH AN INADEQUATE RESPONSE TO FRONTLINE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): RESULTS FROM KARMMA-2 COHORT 2C
title_full_unstemmed P871: IDECABTAGENE VICLEUCEL (IDE-CEL) IN PATIENTS WITH AN INADEQUATE RESPONSE TO FRONTLINE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): RESULTS FROM KARMMA-2 COHORT 2C
title_short P871: IDECABTAGENE VICLEUCEL (IDE-CEL) IN PATIENTS WITH AN INADEQUATE RESPONSE TO FRONTLINE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): RESULTS FROM KARMMA-2 COHORT 2C
title_sort p871: idecabtagene vicleucel (ide-cel) in patients with an inadequate response to frontline autologous stem cell transplantation (asct): results from karmma-2 cohort 2c
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431112/
http://dx.doi.org/10.1097/01.HS9.0000970388.90596.a3
work_keys_str_mv AT alsinamelissa p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c
AT dhodapkarmadhav p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c
AT berdejajesus p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c
AT patelkrina p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c
AT richardshambavi p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c
AT vijravi p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c
AT leleuxavier p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c
AT egandaniel p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c
AT leifbergsagelp p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c
AT ranreshef p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c
AT usmanisaadz p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c
AT truppelhartmannanna p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c
AT basudhardebashree p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c
AT thompsonethan p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c
AT zhengxirong p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c
AT zhongxiaobo p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c
AT greggiochiara p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c
AT popamckivermihaela p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c
AT carrascoalfonsomarlene p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c
AT siegeldavid p871idecabtagenevicleucelidecelinpatientswithaninadequateresponsetofrontlineautologousstemcelltransplantationasctresultsfromkarmma2cohort2c